Skip to content

The effect of UVB irradiation compared with oral vitamin D supplementation on well-being in psycho-geriatric nursing home residents in the Netherlands

The effect of UVB irradiation compared with oral vitamin D supplementation on well-being in psycho-geriatric nursing home residents in the Netherlands - UVB and well-being in nursing home residents

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON43379
Enrollment
80
Registered
2016-04-11
Start date
2016-10-12
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

kwaliteit van leven quality of life vitamin D defficiency

Interventions

Oral vitamin D supplementation (5600 IU/week) or UVB irradiation 2x/week (1,0 SED (standard erythema dose)=1 CIE dose (Comite International de l'Eclairage) of 100 J/m² which is comparable with 50 %

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: nursing home residents, 70 years or above

Exclusion criteria

Exclusion criteria: -contraindications against ultraviolet irradiation: actinic damaged skin including skin cancer, sun allergy, porphyria -contraindications to treatment with vitamin D: hypercalciaemie and sarcoidosis -the use of food supplementation with vitamin D -known agitation, aggression or resistance to physical contact (blood tests)

Design outcomes

Primary

MeasureTime frame
Well-being and quality of life will be measured by 2 scales: the CMAI ( Cohen - Mansfield Agitation Inventory) and the Cornell scale for depression in dementia and will be taken at T0,1,2 (at 0,2 and 6 months)

Secondary

MeasureTime frame
Vitamin D status:25(OH)D serum levels will be taken at T0,1,2 (at 0,2 and 6 months) Other biochemical parameters of calcium homeostasis: serum levels of calcium, alkaline phosphatase, phosphate and parathyroid hormone (PTH) will be taken at T0 and T2

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)